United States Anti Obesity Drugs Market Report 2016

Publisher Name :
Date: 23-Nov-2016
No. of pages: 107
Inquire Before Buying

Notes:

Sales, means the sales volume of Anti Obesity Drugs

Revenue, means the sales value of Anti Obesity Drugs

This report studies sales (consumption) of Anti Obesity Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer

- Merck

- Roche

- GlaxoSmithKline

- AstraZeneca

- Boehringer Ingelheim

- Novo Nordisk

- Eisai

- Norgine

- Arena Pharmaceuticals

- Orexigen Therapeutics

- Vivus

- Alizyme

- Rhythm Pharmaceuticals

- Shionogi

- Zafgan

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Anti Obesity Drugs in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Anti Obesity Drugs Market Report 2016

Table of Contents
United States Anti Obesity Drugs Market Report 2016
1 Anti Obesity Drugs Overview
1.1 Product Overview and Scope of Anti Obesity Drugs
1.2 Classification of Anti Obesity Drugs
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Anti Obesity Drugs
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Anti Obesity Drugs (2011-2021)
1.4.1 United States Anti Obesity Drugs Sales and Growth Rate (2011-2021)
1.4.2 United States Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
2 United States Anti Obesity Drugs Competition by Manufacturers
2.1 United States Anti Obesity Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Anti Obesity Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Anti Obesity Drugs Average Price by Manufactures (2015 and 2016)
2.4 Anti Obesity Drugs Market Competitive Situation and Trends
2.4.1 Anti Obesity Drugs Market Concentration Rate
2.4.2 Anti Obesity Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Anti Obesity Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Anti Obesity Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Anti Obesity Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Anti Obesity Drugs Price by Type (2011-2016)
3.4 United States Anti Obesity Drugs Sales Growth Rate by Type (2011-2016)
4 United States Anti Obesity Drugs Sales (Volume) by Application (2011-2016)
4.1 United States Anti Obesity Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Anti Obesity Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Anti Obesity Drugs Manufacturers Profiles/Analysis
5.1 Pfizer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Anti Obesity Drugs Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Merck
5.2.2 Anti Obesity Drugs Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Merck Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Roche
5.3.2 Anti Obesity Drugs Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Roche Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 GlaxoSmithKline
5.4.2 Anti Obesity Drugs Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 AstraZeneca
5.5.2 Anti Obesity Drugs Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 AstraZeneca Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Boehringer Ingelheim
5.6.2 Anti Obesity Drugs Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Novo Nordisk
5.7.2 Anti Obesity Drugs Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Novo Nordisk Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Eisai
5.8.2 Anti Obesity Drugs Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Eisai Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Norgine
5.9.2 Anti Obesity Drugs Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Norgine Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Arena Pharmaceuticals
5.10.2 Anti Obesity Drugs Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Orexigen Therapeutics
5.12 Vivus
5.13 Alizyme
5.14 Rhythm Pharmaceuticals
5.15 Shionogi
5.16 Zafgan
6 Anti Obesity Drugs Manufacturing Cost Analysis
6.1 Anti Obesity Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Anti Obesity Drugs
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Anti Obesity Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Anti Obesity Drugs Market Forecast (2016-2021)
10.1 United States Anti Obesity Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Anti Obesity Drugs Sales Forecast by Type (2016-2021)
10.3 United States Anti Obesity Drugs Sales Forecast by Application (2016-2021)
10.4 Anti Obesity Drugs Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Anti Obesity Drugs
Table Classification of Anti Obesity Drugs
Figure United States Sales Market Share of Anti Obesity Drugs by Type in 2015
Table Application of Anti Obesity Drugs
Figure United States Sales Market Share of Anti Obesity Drugs by Application in 2015
Figure United States Anti Obesity Drugs Sales and Growth Rate (2011-2021)
Figure United States Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Table United States Anti Obesity Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Anti Obesity Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anti Obesity Drugs Sales Share by Manufacturers
Figure 2016 Anti Obesity Drugs Sales Share by Manufacturers
Table United States Anti Obesity Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Anti Obesity Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Anti Obesity Drugs Revenue Share by Manufacturers
Table 2016 United States Anti Obesity Drugs Revenue Share by Manufacturers
Table United States Market Anti Obesity Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Anti Obesity Drugs Average Price of Key Manufacturers in 2015
Figure Anti Obesity Drugs Market Share of Top 3 Manufacturers
Figure Anti Obesity Drugs Market Share of Top 5 Manufacturers
Table United States Anti Obesity Drugs Sales by Type (2011-2016)
Table United States Anti Obesity Drugs Sales Share by Type (2011-2016)
Figure United States Anti Obesity Drugs Sales Market Share by Type in 2015
Table United States Anti Obesity Drugs Revenue and Market Share by Type (2011-2016)
Table United States Anti Obesity Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anti Obesity Drugs by Type (2011-2016)
Table United States Anti Obesity Drugs Price by Type (2011-2016)
Figure United States Anti Obesity Drugs Sales Growth Rate by Type (2011-2016)
Table United States Anti Obesity Drugs Sales by Application (2011-2016)
Table United States Anti Obesity Drugs Sales Market Share by Application (2011-2016)
Figure United States Anti Obesity Drugs Sales Market Share by Application in 2015
Table United States Anti Obesity Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Anti Obesity Drugs Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Anti Obesity Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Anti Obesity Drugs Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Anti Obesity Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Anti Obesity Drugs Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Anti Obesity Drugs Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Anti Obesity Drugs Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Anti Obesity Drugs Sales Market Share (2011-2016)
Table Eisai Basic Information List
Table Eisai Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Anti Obesity Drugs Sales Market Share (2011-2016)
Table Norgine Basic Information List
Table Norgine Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Norgine Anti Obesity Drugs Sales Market Share (2011-2016)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals Anti Obesity Drugs Sales Market Share (2011-2016)
Table Orexigen Therapeutics Basic Information List
Table Orexigen Therapeutics Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orexigen Therapeutics Anti Obesity Drugs Sales Market Share (2011-2016)
Table Vivus Basic Information List
Table Vivus Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vivus Anti Obesity Drugs Sales Market Share (2011-2016)
Table Alizyme Basic Information List
Table Alizyme Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alizyme Anti Obesity Drugs Sales Market Share (2011-2016)
Table Rhythm Pharmaceuticals Basic Information List
Table Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Rhythm Pharmaceuticals Anti Obesity Drugs Sales Market Share (2011-2016)
Table Shionogi Basic Information List
Table Shionogi Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shionogi Anti Obesity Drugs Sales Market Share (2011-2016)
Table Zafgan Basic Information List
Table Zafgan Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zafgan Anti Obesity Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti Obesity Drugs
Figure Manufacturing Process Analysis of Anti Obesity Drugs
Figure Anti Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015
Table Major Buyers of Anti Obesity Drugs
Table Distributors/Traders List
Figure United States Anti Obesity Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Anti Obesity Drugs Production Forecast by Type (2016-2021)
Table United States Anti Obesity Drugs Consumption Forecast by Application (2016-2021)
  • Global Fatty Liver Disease Drug Sales Market Report 2017
    Published: 07-Dec-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the global Fatty Liver Disease Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Fatty Liver Disease Drug for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global Over The Counter (OTC) Drugs Market Professional Survey Report 2017
    Published: 07-Dec-2017        Price: US 3500 Onwards        Pages: 108
    This report studies Over The Counter (OTC) Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Bayer - GlaxoSmithKline - Johnson & Johnson - Pfizer......
  • Global Glucocorticoid Sales Market Report 2017
    Published: 07-Dec-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the global Glucocorticoid market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Glucocorticoid for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan -......
  • Global Glutamate Receptor Sales Market Report 2017
    Published: 07-Dec-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the global Glutamate Receptor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Glutamate Receptor for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japa......
  • Global Granulocyte Colony Stimulating Factor Drug Sales Market Report 2017
    Published: 07-Dec-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the global Granulocyte Colony Stimulating Factor Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Granulocyte Colony Stimulating Factor Drug for these regions, from 2012 to 2022 (forecast), covering - United State......
  • Global Pharmaceutical Grade Plant Sterol Ester Market Professional Survey Report 2017
    Published: 07-Dec-2017        Price: US 3500 Onwards        Pages: 109
    This report studies Pharmaceutical Grade Plant Sterol Ester in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Raisio - ADM - BASF - Pharmachem Laboratorie......
  • Global Physiological Sea Water Nasal Spray Sales Market Professional Survey Report 2017
    Published: 07-Dec-2017        Price: US 3500 Onwards        Pages: 110
    This report studies Physiological Sea Water Nasal Spray Sales in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - sterimar - Gifrer - LABORATOIRE DE LA MER ......
  • Global PKU Supplements Market Professional Survey Report 2017
    Published: 07-Dec-2017        Price: US 3500 Onwards        Pages: 104
    This report studies PKU Supplements in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Vitaflo - Mead Johnson - Nutricia? - Abbott - Dr. Sch?r......
  • Global Plasma Fractionation Market Professional Survey Report 2017
    Published: 07-Dec-2017        Price: US 3500 Onwards        Pages: 102
    This report studies Plasma Fractionation in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Shire - CSL - Grifols - Octapharma - BPL - Kedrio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs